OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent advancements in exon-skipping therapies using antisense oligonucleotides and genome editing for the treatment of various muscular dystrophies
Jaeho Hwang, Toshifumi Yokota
Expert Reviews in Molecular Medicine (2019) Vol. 21
Closed Access | Times Cited: 29
Jaeho Hwang, Toshifumi Yokota
Expert Reviews in Molecular Medicine (2019) Vol. 21
Closed Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases
Ulf Landmesser, Wolfgang Poller, Sotirios Tsimikas, et al.
European Heart Journal (2020) Vol. 41, Iss. 40, pp. 3884-3899
Open Access | Times Cited: 80
Ulf Landmesser, Wolfgang Poller, Sotirios Tsimikas, et al.
European Heart Journal (2020) Vol. 41, Iss. 40, pp. 3884-3899
Open Access | Times Cited: 80
From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
Hironori Adachi, Martin Hengesbach, Yi‐Tao Yu, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 550-550
Open Access | Times Cited: 58
Hironori Adachi, Martin Hengesbach, Yi‐Tao Yu, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 550-550
Open Access | Times Cited: 58
CRISPR Therapeutics for Duchenne Muscular Dystrophy
Esra Erkut, Toshifumi Yokota
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1832-1832
Open Access | Times Cited: 42
Esra Erkut, Toshifumi Yokota
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1832-1832
Open Access | Times Cited: 42
Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies
Omar Sheikh, Toshifumi Yokota
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 2, pp. 167-176
Closed Access | Times Cited: 56
Omar Sheikh, Toshifumi Yokota
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 2, pp. 167-176
Closed Access | Times Cited: 56
Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot
Harry Wilton-Clark, Toshifumi Yokota
Genes (2022) Vol. 13, Iss. 2, pp. 257-257
Open Access | Times Cited: 24
Harry Wilton-Clark, Toshifumi Yokota
Genes (2022) Vol. 13, Iss. 2, pp. 257-257
Open Access | Times Cited: 24
Preparing for Patient-Customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases
Harry Wilton-Clark, Eric Yan, Toshifumi Yokota
Genes (2024) Vol. 15, Iss. 7, pp. 821-821
Open Access | Times Cited: 6
Harry Wilton-Clark, Eric Yan, Toshifumi Yokota
Genes (2024) Vol. 15, Iss. 7, pp. 821-821
Open Access | Times Cited: 6
Analysis of Exon Skipping Applicability for Dysferlinopathies
Jamie Leckie, Samantha Rodriguez, Martin Krahn, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 177-177
Open Access
Jamie Leckie, Samantha Rodriguez, Martin Krahn, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 177-177
Open Access
Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice
Tatsuhiko Sano, Tetsuya Nagata, Satoe Ebihara, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Tatsuhiko Sano, Tetsuya Nagata, Satoe Ebihara, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Preparing for patient-customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases
Harry Wilton-Clark, Eric Yan, Toshifumi Yokota
(2024)
Open Access | Times Cited: 3
Harry Wilton-Clark, Eric Yan, Toshifumi Yokota
(2024)
Open Access | Times Cited: 3
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
Michael Ablinger, Thomas Lettner, Nicole Friedl, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3326-3326
Open Access | Times Cited: 19
Michael Ablinger, Thomas Lettner, Nicole Friedl, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3326-3326
Open Access | Times Cited: 19
Integrative analyses of gene expression and alternative splicing to gain insights into the effects of copper on hepatic lipid metabolism in swamp eel (Monopterus albus)
Lin Liu, Qiubai Zhou, Changgao Lin, et al.
Aquaculture (2021) Vol. 546, pp. 737367-737367
Closed Access | Times Cited: 17
Lin Liu, Qiubai Zhou, Changgao Lin, et al.
Aquaculture (2021) Vol. 546, pp. 737367-737367
Closed Access | Times Cited: 17
Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6
Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets—Recent Insights at Molecular and Cellular Level
Wolfgang Poller, Susmita Sahoo, Roger J. Hajjar, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2660-2660
Open Access | Times Cited: 6
Wolfgang Poller, Susmita Sahoo, Roger J. Hajjar, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2660-2660
Open Access | Times Cited: 6
Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy
Omar Sheikh, Toshifumi Yokota
BioDrugs (2021) Vol. 35, Iss. 4, pp. 389-399
Closed Access | Times Cited: 14
Omar Sheikh, Toshifumi Yokota
BioDrugs (2021) Vol. 35, Iss. 4, pp. 389-399
Closed Access | Times Cited: 14
Combined transcriptomics and metabolomics analysis reveals lipid metabolic disruption in swamp eel (Monopterus albus) under chronic waterborne copper exposure
Lin Liu, Jianping Fu, Qiongying Tang, et al.
Aquatic Toxicology (2023) Vol. 259, pp. 106520-106520
Closed Access | Times Cited: 4
Lin Liu, Jianping Fu, Qiongying Tang, et al.
Aquatic Toxicology (2023) Vol. 259, pp. 106520-106520
Closed Access | Times Cited: 4
CRISPR/Cas9-mediated exon skipping to restore premature translation termination in a DFNB4 mouse model
Chun-Ying Huang, Yi-Hsiu Tsai, Yi-Fen Cheng, et al.
Gene Therapy (2024)
Closed Access | Times Cited: 1
Chun-Ying Huang, Yi-Hsiu Tsai, Yi-Fen Cheng, et al.
Gene Therapy (2024)
Closed Access | Times Cited: 1
Advances in Treatments in Muscular Dystrophies and Motor Neuron Disorders
Bhaskar Roy, Robert C. Griggs
Neurologic Clinics (2020) Vol. 39, Iss. 1, pp. 87-112
Closed Access | Times Cited: 9
Bhaskar Roy, Robert C. Griggs
Neurologic Clinics (2020) Vol. 39, Iss. 1, pp. 87-112
Closed Access | Times Cited: 9
Nucleic Acid Nanostructure Assisted Immune Modulation
Xiaoli Sun, Haipeng Liu
ACS Applied Bio Materials (2020) Vol. 3, Iss. 5, pp. 2765-2778
Closed Access | Times Cited: 8
Xiaoli Sun, Haipeng Liu
ACS Applied Bio Materials (2020) Vol. 3, Iss. 5, pp. 2765-2778
Closed Access | Times Cited: 8
The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD
E. Gargaun, Sestina Falcone, Guilhem Solé, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 219-219
Open Access | Times Cited: 7
E. Gargaun, Sestina Falcone, Guilhem Solé, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 219-219
Open Access | Times Cited: 7
Design and In Vitro Evaluation of Splice-Switching Oligonucleotides Bearing Locked Nucleic Acids, Amido-Bridged Nucleic Acids, and Guanidine-Bridged Nucleic Acids
Takenori Shimo, Yusuke Nakatsuji, Keisuke Tachibana, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3526-3526
Open Access | Times Cited: 6
Takenori Shimo, Yusuke Nakatsuji, Keisuke Tachibana, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3526-3526
Open Access | Times Cited: 6
Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets – Recent Insights at Molecular and Cellular Level
Wolfgang Poller, Susmita Sahoo, Roger J. Hajjar, et al.
(2023)
Open Access | Times Cited: 2
Wolfgang Poller, Susmita Sahoo, Roger J. Hajjar, et al.
(2023)
Open Access | Times Cited: 2
Top ten discoveries of the year: Neuromuscular disease.
Marta Margeta
DOAJ (DOAJ: Directory of Open Access Journals) (2020) Vol. 1
Closed Access | Times Cited: 4
Marta Margeta
DOAJ (DOAJ: Directory of Open Access Journals) (2020) Vol. 1
Closed Access | Times Cited: 4
CRISP(R)ation musculaire
Océane Ballouhey, Marc Bartoli, Nicolas Lévy
médecine/sciences (2020) Vol. 36, Iss. 4, pp. 358-366
Open Access | Times Cited: 1
Océane Ballouhey, Marc Bartoli, Nicolas Lévy
médecine/sciences (2020) Vol. 36, Iss. 4, pp. 358-366
Open Access | Times Cited: 1
Innate Immunity in Cardiovascular Diseases – Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
(2022)
Open Access | Times Cited: 1
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
(2022)
Open Access | Times Cited: 1
Innate Immunity in Cardiovascular Diseases – Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
(2022)
Open Access | Times Cited: 1
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
(2022)
Open Access | Times Cited: 1
